nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial
Crossref DOI link: https://doi.org/10.1007/s12325-016-0327-4
Published Online: 2016-04-16
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tehfe, Mustapha
Dowden, Scot
Kennecke, Hagen
El-Maraghi, Robert
Lesperance, Bernard
Couture, Felix
Letourneau, Richard
Liu, Helen
Romano, Alfredo
Funding for this research was provided by:
Celgene